Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon1003
Takahiko Horiuchi11
Japon Sauf Takahiko Horiuchi" 993
Takahiko Horiuchi Sauf Japon" 1
Japon Et Takahiko Horiuchi 10
Japon Ou Takahiko Horiuchi 1004
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000F17 Ayako Takaki-Kuwahara [Japon] ; Yojiro Arinobu [Japon] ; Kohta Miyawaki [Japon] ; Hisakata Yamada [Japon] ; Hirofumi Tsuzuki [Japon] ; Kensuke Irino [Japon] ; Masahiro Ayano [Japon] ; Yasutaka Kimoto [Japon] ; Hiroki Mitoma [Japon] ; Mitsuteru Akahoshi [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Hiroaki Niiro [Japon] ; Koichi Akashi [Japon]CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines
001399 Yukimi Otsuka [Japon] ; Chikako Kiyohara [Japon] ; Yusuke Kashiwado [Japon] ; Takuya Sawabe [Japon] ; Shuji Nagano [Japon] ; Yasutaka Kimoto [Japon] ; Masahiro Ayano [Japon] ; Hiroki Mitoma [Japon] ; Mitsuteru Akahoshi [Japon] ; Yojiro Arinobu [Japon] ; Hiroaki Niiro [Japon] ; Koichi Akashi [Japon] ; Takahiko Horiuchi [Japon]Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
001926 Jin Nakagawa [Japon] ; Yoshinobu Koyama [Japon] ; Atsushi Kawakami [Japon] ; Yukitaka Ueki [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Shuji Nagano [Japon] ; Ayumi Uchino [Japon] ; Toshiyuki Ota [Japon] ; Mitsuteru Akahoshi [Japon] ; Koichi Akashi [Japon]A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study.
001C37 Eduardo Mysler [Argentine] ; Carlos Pineda [Mexique] ; Takahiko Horiuchi [Japon] ; Ena Singh [États-Unis] ; Ehab Mahgoub [États-Unis] ; Javier Coindreau [États-Unis] ; Ira Jacobs [États-Unis]Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology
002359 Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
002362 Yasuharu Nakashima [Japon] ; Masakazu Kondo ; Takaaki Fukuda ; Hiroshi Harada ; Takahiko Horiuchi ; Takashi Ishinishi ; Hiroshi Jojima ; Koji Kuroda ; Hisaaki Miyahara ; Masayuki Maekawa ; Hiroaki Nishizaka ; Ryuji Nagamine ; Hitoshi Nakashima ; Takeshi Otsuka ; Eisuke Shono ; Eiichi Suematsu ; Takashi Shimauchi ; Tomomi Tsuru ; Ken Wada ; Shigeru Yoshizawa ; Seiji Yoshizawa ; Yukihide IwamotoRemission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
002460 Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiDrug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
002720 Yasuharu Nakashima [Japon] ; Masakazu Kondo ; Takaaki Fukuda ; Hiroshi Harada ; Takahiko Horiuchi ; Takashi Ishinishi ; Hiroshi Jojima ; Koji Kuroda ; Hisaaki Miyahara ; Masayuki Maekawa ; Hiroaki Nishizaka ; Ryuji Nagamine ; Hitoshi Nakashima ; Takeshi Otsuka ; Eisuke Shono ; Eiichi Suematsu ; Takashi Shimauchi ; Tomomi Tsuru ; Ken Wada ; Shigeru Yoshizawa ; Seiji Yoshizawa ; Yukihide IwamotoRemission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
003432 Rie Suematsu [Japon] ; Akihide Ohta ; Emi Matsuura ; Hiroki Takahashi ; Takao Fujii ; Takahiko Horiuchi ; Seiji Minota ; Yoshiaki Ishigatsubo ; Toshiyuki Ota ; Shuji Takei ; Sachiko Soejima ; Hisako Inoue ; Syuichi Koarada ; Yoshifumi Tada ; Kohei NagasawaTherapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan.
003C69 Yasuharu Nakashima [Japon] ; Masakazu Kondo ; Hiroshi Harada ; Takahiko Horiuchi ; Takashi Ishinishi ; Hiroshi Jojima ; Koji Kuroda ; Hisaaki Miyahara ; Ryuji Nagamine ; Hitoshi Nakashima ; Takeshi Otsuka ; Isao Saikawa ; Eisuke Shono ; Eiichi Suematsu ; Tomomi Tsuru ; Ken Wada ; Yukihide IwamotoClinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021